Regulation
View all stories with this category.
-
OpinionWill Novartis's data manipulation damage relations with regulators?
Trust between the two has been compromised
-
NewsConcerns raised over ‘regrettable’ BPA substitutions
Research indicates chemicals used as alternatives to bisphenol A in polycarbonate plastics and epoxy resins aren’t always safer
-
NewsData manipulation casts shadows on Novartis gene therapy
Manufacturing problems with other new medicines highlight difficulty of developing advanced treatments
-
OpinionAre new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
-
BusinessUS ditches chlorpyrifos ban for food crops
Environmental Protection Agency says evidence of harm from food residues is insufficient
-
BusinessUS judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
NewsUK MPs criticise government inaction on harmful chemicals
A report calls for urgent changes to the way flame retardants and packaging additives are regulated
-
BusinessChina makes slow progress on safety
Government policy drive continues, as self-regulation also grows
-
BusinessUS finalises guidance on biosimilars
Regulator clarifies requirements for allowing substitution between products
-
BusinessIndustry criticises proposed US asbestos ban
Outright ban would compromise chlorine supply and public health, claims trade body